J 2021

One-Stop Management to Initiate Thrombolytic Treatment on the Computed Tomography Table Adoption and Results

HARŠÁNY, Michal; Michal BAR; David CERNIK; Roman HERZIG; René JURA et al.

Základní údaje

Originální název

One-Stop Management to Initiate Thrombolytic Treatment on the Computed Tomography Table Adoption and Results

Autoři

HARŠÁNY, Michal ORCID; Michal BAR; David CERNIK; Roman HERZIG; René JURA; Lubomir JURAK; Jiri NEUMANN; Daniel SANAK; Svatopluk OSTRY; Petr SEVCIK; Ondrej SKODA; David SKOLOUDIK; Daniel VACLAVIK; Ales TOMEK a Robert MIKULÍK

Vydání

JOURNAL OF STROKE, SEOUL, KOREAN STROKE SOC, 2021, 2287-6391

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Korejská republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 8.632

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/21:00122755

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

Thrombolytic Treatment; Computed Tomography Table Adoption

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 17. 5. 2022 11:03, Mgr. Tereza Miškechová

Anotace

V originále

Data from clinical practice show that median door-to-needle time (DNT) for intravenous thrombolysis (IVT) remains around 60 minutes. However, many reports documented that hospital logistics could be substantially streamlined and DNT shortened below 30 minutes. Given Czech stroke care reform, many stroke centers have recently been changing their logistical pathways with the aim to initiate IVT quicker than before.3 Several stroke centers introduced one-stop management, which means that all suspected acute ischemic stroke (AIS) patients are admitted directly to the computed tomography (CT) room and IVT is initiated on the CT table. As a consequence, our national data show that some hospitals were able to reach an extremely short DNT, while others were not. The aim of this nationwide study was to understand how logistical pathways are being used, and how they impact quality of patient care as measured by DNT.

Návaznosti

90128, velká výzkumná infrastruktura
Název: CZECRIN III